Sakamuri Reddy to Osteoclasts
This is a "connection" page, showing publications Sakamuri Reddy has written about Osteoclasts.
Connection Strength
7.169
-
Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption. J Cell Biochem. 2021 10; 122(10):1534-1543.
Score: 0.697
-
Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation. Cytokine. 2020 01; 125:154821.
Score: 0.613
-
Microgravity modulation of syncytin-A expression enhance osteoclast formation. J Cell Biochem. 2018 07; 119(7):5696-5703.
Score: 0.555
-
NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone. Bone. 2017 Aug; 101:236-244.
Score: 0.523
-
Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation. Sci Rep. 2016 05 04; 6:25143.
Score: 0.487
-
Microgravity control of autophagy modulates osteoclastogenesis. Bone. 2014 Apr; 61:125-31.
Score: 0.416
-
Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology. 2011 Nov; 152(11):4180-9.
Score: 0.352
-
Microarray profile of gene expression during osteoclast differentiation in modelled microgravity. J Cell Biochem. 2010 Dec 01; 111(5):1179-87.
Score: 0.334
-
Osteoclast inhibitory peptide-1 binding to the Fc gammaRIIB inhibits osteoclast differentiation. Endocrinology. 2010 Sep; 151(9):4389-99.
Score: 0.325
-
Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem. 2008 Jul 01; 104(4):1500-8.
Score: 0.283
-
RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res. 2007 Jan 01; 313(1):168-78.
Score: 0.251
-
Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. Gene. 2006 Apr 12; 371(1):16-24.
Score: 0.238
-
Etiology of Paget's disease and osteoclast abnormalities. J Cell Biochem. 2004 Nov 01; 93(4):688-96.
Score: 0.219
-
Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr. 2004; 14(4):255-70.
Score: 0.207
-
CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation. J Bone Miner Res. 2003 Mar; 18(3):458-65.
Score: 0.195
-
Identification of the functional domain of osteoclast inhibitory peptide-1/hSca. J Bone Miner Res. 2002 Jan; 17(1):111-8.
Score: 0.180
-
Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells. J Cell Physiol. 2018 08; 233(8):6125-6134.
Score: 0.138
-
SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone. J Cell Biochem. 2013 Sep; 114(9):2032-8.
Score: 0.101
-
NIP45 negatively regulates RANK ligand induced osteoclast differentiation. J Cell Biochem. 2012 Apr; 113(4):1274-81.
Score: 0.092
-
Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy. J Pathol. 2009 Sep; 219(1):52-60.
Score: 0.077
-
FGF-2 stimulation of RANK ligand expression in Paget's disease of bone. Mol Endocrinol. 2009 Sep; 23(9):1445-54.
Score: 0.076
-
PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood. 2009 Mar 05; 113(10):2202-12.
Score: 0.072
-
Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling. J Child Neurol. 2007 Aug; 22(8):967-73.
Score: 0.066
-
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest. 2007 Jan; 117(1):133-42.
Score: 0.064
-
Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 Aug 15; 177(4):2384-90.
Score: 0.062
-
RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells. J Cell Biochem. 2006 Apr 15; 97(6):1362-9.
Score: 0.061
-
Etiologic factors in Paget's disease of bone. Cell Mol Life Sci. 2006 Feb; 63(4):391-8.
Score: 0.060
-
Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res. 2006 Mar; 21(3):446-55.
Score: 0.059
-
Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res. 2005 Jul; 20(7):1161-7.
Score: 0.056
-
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease. Endocrinology. 2005 Apr; 146(4):2023-30.
Score: 0.055
-
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004 Aug; 114(4):475-84.
Score: 0.054
-
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):331-4.
Score: 0.053
-
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J Bone Miner Res. 2004 Jul; 19(7):1154-64.
Score: 0.053
-
Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells. J Biol Chem. 2004 Mar 12; 279(11):10500-7.
Score: 0.052
-
Experimental models of Paget's disease. J Bone Miner Res. 2006 Dec; 21 Suppl 2:P55-7.
Score: 0.016
-
Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem. 2006 Oct 13; 281(41):30542-50.
Score: 0.016
-
Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res. 2002 Jan; 17(1):145-51.
Score: 0.011